|
2023
|
Invention
|
Chromanol compounds for treatment or prophylaxis of ageing-associated disorders. The invention re... |
|
2021
|
Invention
|
Compounds for treatment of heart failure.
The invention relates to certain chromanol, quinone or... |
|
|
Invention
|
Chromanol compounds for treatment of heart failure. The invention relates to certain chromanol, q... |
|
|
Invention
|
Chromanol, quinone or hydroquinone compounds for treatment of sepsis.
The invention relates to c... |
|
|
Invention
|
Chromanol, quinone or hydroquinone compounds for treatment of sepsis. The invention relates to ce... |
|
|
Invention
|
Compounds for protection of cells.
This invention is related to a compound with the structural f... |
|
2020
|
Invention
|
Compounds for treatment of alzheimer's disease.
The invention relates to certain chromanol, quin... |
|
|
Invention
|
Compounds for treatment of alzheimer's disease. The invention relates to certain chromanol, quino... |
|
|
Invention
|
Compound for the prophylaxis or treatment of organ damage.
The present invention relates to comp... |
|
2018
|
Invention
|
Compounds for protection of cells. This invention is related to a compound with the structural fo... |
|
|
Invention
|
Medicaments for the treatment of vasoconstriction related diseases or disorders. The present inve... |
|
|
Invention
|
6-chromanol derivatives for use as a medicament. The present invention relates to the (S) enantio... |
|
|
Invention
|
6-hydroxy-2,5,7,8-tetramethylchroman-compounds for the treatment of chronic obstructive airway di... |
|
2016
|
Invention
|
Compound for the prophylaxis or treatment of organ damage. The present invention relates to compo... |
|
2013
|
Invention
|
Compounds for protection of cells. The invention relates to (6-hydroxy-2,5,7,8- tetramethylchroma... |
|
2011
|
Invention
|
Compounds for prevention of cell injury.
The invention is related to compounds for prevention of... |
|
|
Invention
|
Compounds for prevention of cell injury. The invention is related to compounds for prevention of ... |
